A Novel Bispecific Immunotoxin Delivered by Human Bone Marrow-Derived Mesenchymal Stem Cells to Target Blood Vessels and Vasculogenic Mimicry of Malignant Gliomas
- Type
- Retraction
- Notice date
- 9/2/2021 0:00
- Journal
- Drug Design, Development and Therapy
- Publisher
- Taylor and Francis - Dove Press
- Notice DOI
- 10.2147/dddt.s336973
- Original paper DOI
- 10.2147/dddt.s79475